Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Increased Prescribing of Psychotropic Medications to Ontario Nursing Home Residents during the COVID-19 Pandemic

View ORCID ProfileNathan M. Stall, View ORCID ProfileJonathan S. Zipursky, Jagadish Rangrej, View ORCID ProfileAaron Jones, View ORCID ProfileAndrew P. Costa, View ORCID ProfileMichael P. Hillmer, View ORCID ProfileKevin Brown
doi: https://doi.org/10.1101/2020.11.26.20239525
Nathan M. Stall
1Division of General Internal Medicine and Geriatrics, Sinai Health System and the University Health Network, Toronto, Canada
2Department of Medicine, University of Toronto, Toronto, Canada
3Women’s College Research Institute, Women’s College Hospital, Toronto, Canada
4Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nathan M. Stall
  • For correspondence: nathan.stall@sinaihealth.ca
Jonathan S. Zipursky
1Division of General Internal Medicine and Geriatrics, Sinai Health System and the University Health Network, Toronto, Canada
2Department of Medicine, University of Toronto, Toronto, Canada
4Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan S. Zipursky
Jagadish Rangrej
5Capacity Planning and Analytics, Ontario Ministry of Health, Toronto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron Jones
6Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
7ICES, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aaron Jones
Andrew P. Costa
6Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
7ICES, Toronto, Canada
8Schlegel Chair in Clinical Epidemiology and Aging, McMaster University, Hamilton, Ontario, Canada
9Centre for Integrated Care, St. Joseph’s Health System, Hamilton, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew P. Costa
Michael P. Hillmer
4Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
5Capacity Planning and Analytics, Ontario Ministry of Health, Toronto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael P. Hillmer
Kevin Brown
10Infection Prevention and Control, Public Health Ontario, Toronto, Canada
11Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kevin Brown
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

In this population-based study of all Ontario nursing home residents, we found increased prescribing of psychotropic drugs at the onset of the COVID-19 pandemic that persisted through September 2020. Increases in prescribing were out of proportion to expected secular trends, and distinct from observed prescribing changes in other drugs during the pandemic. Our findings underscore the urgency of balancing infection prevention and control measures in nursing homes with the mental wellbeing of residents.

Introduction

An enduring feature of the COVID-19 pandemic is the sizeable number of outbreaks and deaths in nursing homes. To limit the introduction of virus in these settings, strict and lengthy lockdowns were imposed on nursing homes worldwide. These restrictions have led to concerns about the mental health of nursing home residents, and increases in the use of psychotropic medications, which were frequently overprescribed prior to the pandemic.1,2

Methods

We examined the monthly proportion of nursing home residents in Canada’s most populous province of Ontario dispensed psychotropics from January–September 2020. As of March 1, 2020, there were 77,291 residents living in the province’s 623 licensed nursing homes receiving personal and nursing care, subsidized accommodation and all prescription medications under a publicly long-term care program. Restrictions on visitation, absences, and most congregate dining and group activities began in all nursing homes on March 14, 2020.

We studied the dispensation of four psychotropic medications: antipsychotics (1st-and-2nd generation), antidepressants (SSRIs, SNRIs, bupropion, mirtazapine), benzodiazepines, and trazodone. We also examined the prescribing of two negative tracer drugs (metformin and statins) not expected to change during the pandemic. Data were obtained from the Ontario Drug Benefit database through the Ministry of Health as part of the province’s COVID-19 Modeling Consensus Table.

We examined the proportion of residents receiving a prescription across the first seven months of the pandemic (March-September 2020). To account for the dynamic number of residents living in nursing homes during the pandemic, we calculated the monthly number of residents filling a prescription for each drug of interest as a proportion of the monthly number of residents filling a prescription for any drug. In unadjusted analyses, we examined absolute changes in the proportion of residents receiving a prescription compared to the most recent pre-pandemic months (January-February 2020). In adjusted analyses, we examined absolute changes compared to anticipated absolute prescribing trends based on the linear secular trend of prescribing rates from April 2019 to February 2020. All analyses were based on logistic regression. The study was approved by the University of Toronto’s research ethics board.

Results

Comparing January-February 2020 with September 2020 (Table 1), there were absolute increases in the proportion of nursing home residents who received prescriptions for antipsychotics (1.6%, 95% Confidence Internal (CI): 0.9–2.4), antidepressants (1.6%, 95%CI: 1.0–2.2), and trazodone (1.0%, 95%CI: 0.3–1.8). While benzodiazepine prescribing decreased slightly (−0.2%, 95%CI: - 1.0–0.6), the adjusted analysis (Figure 1) revealed an increase relative to apparent negative secular trends (0.3%, 95%CI: −0.3–0.9). Deviations above positive secular trends were also present in adjusted analyses for all other psychotropics, including antipsychotics (1.7%, 95%CI: 1.1–2.2), antidepressants (1.4%, 95%CI: 0.9–1.8), and trazodone (1.1%, 95%CI: 0.6–1.7). Comparatively, there were decreases in the proportion of residents prescribed metformin (−0.3%, 95%CI: −1.1–0.5) and statins (−0.7%, 95%CI: −1.4–0.1), and these decreases were more pronounced after adjustment for secular trends (−0.6%, 95%CI:-1.2–0.0 and −1.4%, 95%CI: −1.9– −0.8, respectively).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1:

Unadjusted and adjusted absolute changes in psychotropic drug prescribing to nursing home residents in Ontario, Canada (January-September, 2020)

Figure 1:
  • Download figure
  • Open in new tab
Figure 1: Changes in psychotropic drug prescribing to nursing home residents in Ontario, Canada (April 2019 through September 2020)

Monthly proportion of residents filling a prescription for each drug class from April 2019 to September 2020. As of March 1, 2020, there were 77,291 residents living in Ontario’s 623 licensed nursing homes. The grey vertical line represents the onset of the COVID-19 lockdown in Ontario (March 2020). The blue line represents expected prescribing based on secular trends prior to the lockdown.

Discussion

In this population-based study of all Ontario nursing home residents, we found increased prescribing of psychotropic drugs at the onset of the COVID-19 pandemic that persisted through September 2020. Increases in prescribing were out of proportion to expected secular trends, and distinct from observed prescribing changes in other drugs during the pandemic.

Our results align with findings of increased prescribing of antipsychotics during the pandemic to people living with dementia in the United Kingdom.3 We offer additional insights by studying prescribing of multiple classes of psychotropic drugs, as well as those unexpected to change during the pandemic. Our study is limited by lack of data on prescribing indications; while some of the observed increases in psychotropics may be for palliative management of residents dying of COVID-19, increases were more likely related to the effects of prolonged social isolation during lockdowns.4,5 Due to diminished resources, clinicians may have been less likely to prioritize more favorable non-pharmacological management for common issues like responsive behaviours. Overall, our findings underscore the urgency of balancing infection prevention and control measures in nursing homes with the mental wellbeing of residents.6

Data Availability

Study protocol and statistical code: The study protocol and underlying analytic code are available from the authors on request (e-mail, nathan.stall@mail.utoronto.ca), with the understanding that the computer programs may rely on coding templates or macros that are unique to the Ontario Ministry of Health and therefore either are inaccessible or may require modification. Data set: The data used for this study are not publicly available.

Financial Support

This study was not funded. Dr. Stall is supported by the University of Toronto Department of Medicine’s Eliot Phillipson Clinician-Scientist Training Program and the Vanier Canada Graduate Scholarship.

Disclosures

The authors have no conflicts of interest to disclose.

Footnotes

  • ↵* Co-first authors

References

  1. 1.↵
    Abbasi J. Social Isolation-the Other COVID-19 Threat in Nursing Homes. JAMA. 2020.
  2. 2.↵
    Rochon PA, Stukel TA, Bronskill SE, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med. 2007;167(7):676–683.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    Howard R, Burns A, Schneider L. Antipsychotic prescribing to people with dementia during COVID-19. Lancet Neurol. 2020;19(11):892.
    OpenUrl
  4. 4.↵
    Van der Roest HG, Prins M, van der Velden C, et al. The impact of COVID-19 measures on well-being of older long-term care facility residents in the Netherlands. Journal of the American Medical Directors Association. 2020.
  5. 5.↵
    Cagnin A, Di Lorenzo R, Marra C, et al. Behavioral and Psychological Effects of Coronavirus Disease-19 Quarantine in Patients With Dementia. Front Psychiatry. 2020;11:578015.
    OpenUrlCrossRef
  6. 6.↵
    Bergman C, Stall NM, Haimowitz D, et al. Recommendations for Welcoming Back Nursing Home Visitors during the COVID-19 Pandemic: Results of a Delphi Panel. Journal of the American Medical Directors Association. 2020.
Back to top
PreviousNext
Posted November 30, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Increased Prescribing of Psychotropic Medications to Ontario Nursing Home Residents during the COVID-19 Pandemic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Increased Prescribing of Psychotropic Medications to Ontario Nursing Home Residents during the COVID-19 Pandemic
Nathan M. Stall, Jonathan S. Zipursky, Jagadish Rangrej, Aaron Jones, Andrew P. Costa, Michael P. Hillmer, Kevin Brown
medRxiv 2020.11.26.20239525; doi: https://doi.org/10.1101/2020.11.26.20239525
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Increased Prescribing of Psychotropic Medications to Ontario Nursing Home Residents during the COVID-19 Pandemic
Nathan M. Stall, Jonathan S. Zipursky, Jagadish Rangrej, Aaron Jones, Andrew P. Costa, Michael P. Hillmer, Kevin Brown
medRxiv 2020.11.26.20239525; doi: https://doi.org/10.1101/2020.11.26.20239525

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Geriatric Medicine
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8783)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1861)
  • Geriatric Medicine (178)
  • Health Economics (388)
  • Health Informatics (1291)
  • Health Policy (644)
  • Health Systems and Quality Improvement (491)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10557)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1754)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (461)
  • Oncology (964)
  • Ophthalmology (282)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (117)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1843)
  • Public and Global Health (3983)
  • Radiology and Imaging (654)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)